Operant responses involving a cued discrimination are StnSitively disrupted by neuroleptic drugs that block dopamine (DA) receptors in the brain; however, it is not dtar which DA receptor subtypes may be involved in these effects. The role of Dl or D2 DA receptor
Selective Effects of Low-Dose D2 Dopamine Receptor Antagonism in a Reaction-Time Task in Rats Marianne Amalric, Ph.D., Melissa Berhow, B.S., Ilham Polis, B.S., and George F. Koob, Ph.D. Operant responses involving a cued discrimination are StnSitively disrupted by neuroleptic drugs that block dopamine (DA) receptors in the brain; however, it is not dtar which DA receptor subtypes may be involved in these effects. The role of Dl or D2 DA receptor
I1Itagonists on the execution of a conditioned reaction time (RT) motor task was investigated in the present study. Rats were trained to release a lever after the presentation of a visual cue within a RT limit to be rrinforced by a food pellet. The Dl receptor antagonist SCH-23390, at doses that significantly decrease the behavioral effects of cocaine, did not impair performance ,/ any dose (5, 10, or 20 J1.glkg) injected subcutaneously. drugs that block OA receptors in the brain (Wise 1982) suppress operant responses reinforced with food, brain stimulation, or stimulant drugs. Furthermore, dopa minergic receptor blockade or neurotoxic lesions of the brain DA system also induce motor and cognitive debcits. The subdivision of OA receptors into 01 and In contrast, a selective D2 receptor antagonist raclopride (50, 100, or 200 J1.glkg) induced a dose-dependent increase in the number of incorrect responses (release of the lever over the RT limit) associated with an increase in the RT. The results suggest that the dopaminergic nigrostriatal system, which has previously been shown to be specifically involved in this RT task (Amalric and Koob 1987) , appears to be a sensitive site for sensorimotor integration, and that the execution of the conditioned RT motor task may depend preferentially on the activation of the dopaminergic D2 receptors in this system. lNeuropsychopharmacology 8:195-200, 1993] 02 sites (Kebabian and Calne 1979) on the basis of in vitro physiological and biochemical studies has opened questions as to the functional differences of these two receptors.
Most of the neuroleptic drugs are antagonists at both receptor subtypes. However, the recently devel oped OA antagonist, raclopride, has a high affinity for the 02 OA receptor and crosses the blood-brain barrier fairly easily, reaching its peak concentration at about 15 minutes after intravenous injection (Kohler et al. 1985) . Raclopride has no effect on the activity of ade nylate cyclase, indicating the absence of action on the 01 receptors (Ogren et al. 1986 ). On the other hand, the drug SCH-23390 has a very high affinity for the OA 01 receptor, as compared to its affinity for the 02 receptor (Billard et al. 1984; Hyttel 1983; Hjorth and Carlsson 1988) Behavioral studies have indicated a role for the mesocorticolimbic dopaminergic system in the medi ation of the pharmacological actions of psychomotor stimulants such as amphetamine or cocaine. Dopamine in the nucleus accumbens appears to be involved in the reinforcing and locomotor hyperactivity induced by psychomotor stimulants Roberts et al. 1980 Roberts et al. , 1982 Yokel and Wise 1978; Le Moal and Si mon 1991) . Whether these behavioral effects are medi ated through the activation of Dl or D2 DA receptors is still a matter of discussion Wool verton and Virus 1989; Nakajima and Baker 1989; Ac quas et al. 1989; Hiroi and White 1991) . In contrast, the striatum, receiving dopaminergic afferents (the nigro striatal DA pathway) as well as cortical and thalamic inputs, plays a crucial role in the initiation and the se quencing of conditioned motor acts (for review, see Iver sen 1977).
Previous work has shown that destruction of the DA nigrostriatal pathway signifIcantly impaired reac tion-time (RT) performance (Amalric and Koob 1987) .
Furthermore, the blockade of the dopaminergic recep tors with a DIID2 receptor antagonist (haloperidol) within the striatum disrupted this RT motor task and increased RTs (Amalric and Koob 1989 ). The present study was designed to investigate a potential differen tial role of the two dopaminergic receptors Dl and D2 in the execution of the RT motor task. For this purpose, the effects of the Dl receptor antagonist, SCH-23390, or the D2 receptor antagonist, raclopride, injected sub cutaneously, were measured on the performance of rats trained to release a lever in a food-motivated RT task.
MATERIALS AND METHODS

Thirty-two male albino Wistar rats (Charles River
Laboratories) weighing between 160 and 180 g were maintained on a 12-hour light/dark cycle, with lights on at 7 A.M. Rats were deprived of food for 48 hours, then meal-deprived by restricting the amount of food provided to 15 to 17 g per day per rat. This restriction caused no undue stress to the animals and the animals steadily gained weight during the course of the experi ment. After the completion of the experiment (2 months) rats' weight ranged from 290 to 390 g.
Procedure
As previously reported (Amalric and Koob 1987) animals are fIrst trained to press down a lever for food Rats were trained to press a lever down and wait for a visual cue (a light located above the lever). The CS occurs at ran· dom after four different delays (0.25 to 1.0 sec). The animals then had to release the lever in a fast movement contr olled in a RT. Reaction times were measured as the time period from the CS to the lever release. If the rat failed and releas ed the lever before the CS (AN error), no reward was given and a new trial had to be initiated. If the rat waited for the cue, then released the lever after the RT -limit restriction (700 msec), the trial was also not rewarded. Each correct trial was rein forced with a 45-mg Noyes food pellet and the daily session ended after 100 trials. LG is the release of the lever after 700 rosec, with the RT also measured in milliseconds), were counted separately.
Drug Treatment
After stabilization of their performance (1 month), the animals were divided into two groups (n = 16 in each group LG per session was 10 for both groups with a mean RT averaging 1500 msec).
The pretreatment with the D1 DA receptor an tagoni st (SCH-23390, 5 to 20 Ilg/kg) did not modify the motor performance at any dose tested (Fig. 2) . The animals per formed the RT task with the same rate of correct trials as during the control sessions (data not shown). A correct trial is a lever release before the RT limit restriction (700 msec after the CS). An AN error is a re lease of the lever before the visual CS. An LG error is a re lease of the lever after the time-liIriit restriction.
from an increased number of long trials as shown by a signifIcant interaction between dose and sessions (ANOV A: F = 21.34, df = 3,45, P < .01) (Fig. 3) . In dividual comparisons of means, using a paired t-test,
showed that the three doses tested signifIcantly in creased the number of long trials, as compared to con trol values. Two of the 16 animals receiving the highest doses did not reach the criterion of 100 lever presses within the session. They stopped pressing the lever af ter 60 trials and remained in a state of prostration away from the lever. No signifIcant change in the correct RTs (below 700 msec) was observed after raclopride treat ment, except with the lowest dose (50 Ilg/kg). However, the RTs of non-rewarded trials (over 700 msec) were dramatically increased in a dose-dependent manner (ANOVA: F = 14.10, df = 3,45, P < .01) as shown in Performance of rats in the RT task after pretreatment with rac10pride injected subcutaneously 30 minutes before the test. A correct trial is a lever release before the RT-limit restriction (700 msec after the CS). An AN error is a release of the lever before the visual CS. An LG error is a release of the lever after the time-limit restriction. Asterisks indicate significant diff erence from control values (p < .05, paired t-test) following signifIcant ANOV A.
reinforcing effects or the locomotor stimulation induced by cocaine (Koob et aI. 1987; Cabib et al. 1991 ) and d-amphetamine in rats (Mailman et al. 1984) do not im pair performance of an appetitive simple RT motor task.
However, the selective 02 receptor antagonist raclo pride in doses of 50, 100, and 200 Ilg/kg induced a dose dependent disruption of the same task. This disrup tion was characterized by decreases in the number of correct responses that were wholly attributable to in creases in the time to release the lever after the cue.
The ability of raclopride (50 to 300 Ilg/kg) and SCH-23390 (5 to 20 Ilg/kg) to produce catalepsy has been tested using the horizontal bar. As previously shown by others, SCH-23390 did not elicit catalepsy at the three doses tested. The EOso to produce catalepsy, calcu lated by others, was shown to vary between 20 to 80 Ilg/kg (Morelli and Oi Chiara 1985; Meller et al. 1985) .
Raclopride at low doses (50 and 100 Ilg/kg) did not pro duce catalepsy either, whereas higher doses were found to be cataIeptogenic (A. Ouagazzal et al., unpublished However, the hypothesis of a possible reduced "rein forcement value II of the food reward cannot be ruled out as it could also result in an impairment of the mo tor performance. Nevertheless, an "extinction-like" re sponse (increase in the number of lever releases fol lowed by a decrease in performance) would be expected in this case. This was not observed in the present study.
The change in performance induced by raclopride resembles closely the deficits in RT performance previ ously observed with the mixed 01/02 antagonist a-flu penthixol (Amalric and Koob 1987) and systemic halo peridol (unpublished data). Perhaps more importantly, this same profIle of increases in RT was observed after roth DA depletions of the corpus striatum (Amalric and Koo b 1987) and intracaudate infusions of haloperidol (Amalric and Koob 1989) . A similar increase in operant response duration was observed by others after sys temic injections of haloperidol at low doses (Liao and Fowler 1990; Fowler et a1. 1986; Meck 1986 There is some evidence from neurochemical studies that D2 antagonists at low doses may preferentially aff ect the nig rostriatal system. It is striking to note that tritiated ligands of the same DA antagonists used in the present stud y show that there is a higher relative bind ing of raclopride in the corpus striatum (Kohler et al. 1985 ) and a higher relative binding of SCH-23390 in the nucleus accumbens in the rat (A. Pert, personal com munication). Furthermore, autoradiographic studies have also revealed a lateral to medial gradient of D2-receptor density in the rat striatum (Joyce et a1. 1985) , which corresponds to anatomical and biochemical diff erences in the striatum, such as a higher choliner gic activity in the lateral striatum. This acetylcholine rich lateral part of the striatum also receives a cortical inn ervation from the sensorimotor cortex. Altogether, these res ults suggest a direct relationship between the � receptors and sensorimotor functions of the stria tum Goyce et al. 1985) , although a difference in the rel ative density of the D1 and D2 receptors, as demon strated by binding studies in different brain structures, does not necessarily imply a functional role.
A preferential involvement of D2 agonists or anta gonists in the expression of nigrostriatal dopaminergic functions is also supported by behavioral experiments.
Infusion of a D2 DA receptor agonist, quinpirole, in tracerebroventricularly into rats with 6-hydroxydopa mine (6-0HDA) lesions of the midbrain DA system produces more stereotyped behavior than intracere broventricular infusions of a D1 agonist, SKF-38393, and conversely intraaccumbens infusions of SKF-38393 were more effective than quinpirole in eliciting locomo tor activity in these rats (Breese et al. 1987 ). Similar results have been seen with microinjections of SKF-38393 and quinpirole into the ventrolateral striatum (Delfs and Kelley 1990) . Consistent with these obser vations, SCH-23390 has recently been shown to block the hyperlocomotion produced by cocaine, whereas selective D2 antagonists only blocked cocaine-induced locomotion at hypokinetic doses (Cabib et al. 1991) .
Oearly, the impairment of the RT task controlled Dopamine Receptor Antagonism in Reaction Time 199 by dopaminergic activity in the corpus striatum would be dependent on the dose of the drugs employed.
Higher doses of SCH-23390 clearly produce pro nounced motor disturbances and catalepsy (Ioro et a1. 1983; Creese and Chen 1985; Hjorth and Carlsson 1988) , and animals will completely stop responding in any operant situation. In contrast, lower doses of SCH-23390 within the same dose range as tested in the pres ent study have been found to selectively reverse DA mediated behaviors, known to involve mesolimbic DA hyperactivity. For example, SCH-23390 (3 to 20 Ilg/kg) signifIcantly reduced the stimulant effect of cocaine on locomotion (Cabib et al. 1991 ) and the hyperlocomotor activity following apomorphine injection in rats with 6-0HDA lesion of the mesolimbic terminals in the nu cleus accumbens (Amalric et al. 1987; Mailman et al. 1984) . Furthermore, the rewarding properties of psy chostimulants (cocaine and d-amphetarnine), which are thought to reflect an activation of the mesolimbic DA system, are also blocked by low doses of SCH-23390 (5 to 40 Ilg/kg) (Koob et a1. 1987; Hiroi and White 1991) .
The possibility of selectively affecting a given func tion of the striatal or mesolimbic DA system by systemic injections of a selective receptor subtype antagonist has important implications for the therapeutic use of these compounds. For example, there is some evidence to suggest that chronic treatment with D1 antagonists does not produce the acute extrapyramidal syndrome observed with D2 antagonists (Coffin et al. 1989 ). Thus at the low end of the dose-effect functions it may be possible to selectively access the function of the nigro striatal or meso limbic systems and affect their respec tive therapeutic effects.
